To: topgun_06903 who wrote (9862 ) 1/18/1999 9:07:00 AM From: topgun_06903 Read Replies (1) | Respond to of 15094
The hell with this weeks news, I'm still drooling over news of 2 months ago. Last weeks news on MCK. Let the imagination run wild??!! There all ours, think about it??!! Thursday January 14, 1:00 pm Eastern Time Company Press Release SOURCE: McKesson HBOC, Inc. McKesson HBOC, Inc. Presents at the Hambrecht & Quist 17th Annual Healthcare Conference Mark A. Pulido, President and Chief Executive Officer 9 AM PST, January 14, 1999 SAN FRANCISCO, Jan. 14 /PRNewswire/ -- McKesson HBOC, Inc., (NYSE: MCK - news; mckhboc.com ) is the world's largest healthcare services company. McKessonHBOC provides pharmaceutical supply management and information technologies across the entire continuum of healthcare, including market-leading businesses in pharmaceutical and medical-surgical distribution, information technology for healthcare providers, services for payors and outsourcing. McKessonHBOC has the largest customer base in the industry, serving approximately 5,000 hospitals, 25,000 retail pharmacies, 200,000 physicians, 10,000 long-term care sites, 750 home care agencies, 600 healthcare payors, 450 pharmaceutical manufacturers and 2,000 medical-surgical manufacturers. While more than 95 percent of McKessonHBOC's revenues come from the U.S. healthcare market, the company also has customers in 10 other countries. McKessonHBOC has achieved a three-year compound annual growth rate of 35% for earnings per share and 48% for total shareholder return. It has $3 billion in stockholders' equity, an ''A'' credit rating, significant free cash flow to fund continued growth and additional product development and financial flexibility to take advantage of supply management and healthcare technology investment opportunities. McKesson HBOC, Inc. is the leader in fast-growing U.S. healthcare segments: the $100-billion pharmaceutical market, the $40-billion medical-surgical market and the $20-billion information technology market. Favorable dynamics are driving growth in each of our markets. McKessonHBOC pharmaceutical sales are growing in excess of 15 percent per year and healthcare information technology revenues are increasing at a rate of more than 25 percent per year. The company's businesses have a proven track record for providing information-based solutions that reduce costs and improve quality for their customers. By coordinating the comapny's product and service offerings, it can reduce steps in the healthcare delivery process, and thereby reduce costs and improve quality for their customers, and accelerate McKessonHBOC revenue growth. The affiliation of McKesson and HBOC creates opportunities for pull through of current pharmaceutical supply management and information technology and service offerings, as well as new products, leveraging the company's substantial customer base. The newly formed McKessonHBOC Affiliation Team has a goal to identify two to three major projects that will deliver significant incremental pre-tax income each year. They have a target of pre-tax synergies in excess of $75 million in fiscal year 2000 and a target of $125 million in the following fiscal year. As a result, the company anticipates acceleration of historically strong growth to create further value for our shareholders, with goals for fiscal years 1999, 2000 and 2001 of 35% earnings per share growth, 20+% return on equity and 30+% return on committed capital. SOURCE: McKesson HBOC, Inc. More Quotes and News: McKesson Corp (NYSE:MCK - news) Related News Categories: household/consumer, medical/pharmaceutical Help Copyright © 1999 PRNewswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.